• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bausch Health Companies Inc (NY: BHC )

    6.825 -0.745 (-9.84%)
    Streaming Delayed Price Updated: 9:53 AM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,633,246
    Open 7.530
    Bid (Size) 6.820 (20)
    Ask (Size) 6.830 (34)
    Prev. Close 7.570
    Today's Range 6.800 - 7.580
    52wk Range 6.050 - 11.46
    Shares Outstanding 358,808,755
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Bausch Health Welcomes Two New Members to the Executive Leadership Team
    Via ACCESSWIRE
    Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
    Via ACCESSWIRE

    Performance

    YTD
    -12.28%
    -12.28%
    1 Month
    -0.07%
    -0.07%
    3 Month
    -19.99%
    -19.99%
    6 Month
    -16.77%
    -16.77%
    1 Year
    -28.68%
    -28.68%

    More News

    Read More
    Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
    Via ACCESSWIRE
    Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
    Via ACCESSWIRE
    Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults
    Via ACCESSWIRE
    Bausch Health Announces 2024 Annual Meeting of Shareholder Results
    Via ACCESSWIRE
    Why Bausch Health Companies Shares Are Falling After Q1 Results
    Via Benzinga
    Bausch Health Announces First Quarter 2024 Results
    Via ACCESSWIRE
    Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
    Via ACCESSWIRE
    Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
    Via ACCESSWIRE
    Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
    Via ACCESSWIRE
    Why Bausch Health Companies Stock Dived by More Than 7% Today
    Via The Motley Fool
    BHC Stock Earnings: Bausch Health Companies Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Preview: Bausch Health Companies's Earnings
    Via Benzinga
    Bausch Health to Announce First-Quarter 2024 Results on May 2
    Via ACCESSWIRE
    Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
    Via ACCESSWIRE
    Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
    Via ACCESSWIRE
    Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
    Via ACCESSWIRE
    Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
    Via ACCESSWIRE
    Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
    Via ACCESSWIRE
    Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
    Via ACCESSWIRE
    New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
    Via ACCESSWIRE
    Bausch Health Companies to Present at Cowen Annual Health Care Conference
    Via ACCESSWIRE
    RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know
    Via Benzinga
    Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.